MEK抑制剂PD0325901显著提高猪胎儿成纤维细胞ssODN介导的HDR效率

doi:10.16288/j.yczz.18-294

遗传 ›› 2019, Vol. 41 ›› Issue (4): 327-336.doi: 10.16288/j.yczz.18-294

MEK抑制剂PD0325901显著提高猪胎儿成纤维细胞ssODN介导的HDR效率

欧浩¹,李国玲¹,王豪强¹,黄广燕¹,蔡更元^1,²,李紫聪¹,吴珍芳^1,²,张献伟^1,²()

^1. 华南农业大学动物科学学院,国家生猪种业工程技术研究中心,广州 510642
^2. 温氏食品集团股份有限公司,新兴 527400

收稿日期:2018-10-29 修回日期:2019-03-02 出版日期:2019-04-20 发布日期:2019-03-25
通讯作者: 张献伟 E-mail:zxianw@163.com
作者简介:欧浩,硕士,专业方向：动物遗传育种。E-mail: 719367112@qq.com。|李国玲,博士,研究方向：基因编辑与遗传育种。E-mail: 792268184@qq.com。
基金资助:
国家自然科学基金项目(31772555);国家转基因重大专项(2016ZX08006002)

MEK inhibitor PD0325901 significantly boosts ssODN-mediated HDR efficiency in porcine fetal fibroblasts

Ou Hao¹,Li Guoling¹,Wang Haoqiang¹,Huang Guangyan¹,Cai Gengyuan^1,²,Li Zicong¹,Wu Zhenfang^1,²,Zhang Xianwei^1,²()

^1. National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou 510642, China
^2. Wens Foodstuff Group Co., Ltd, Xinxing 527400, China

Received:2018-10-29 Revised:2019-03-02 Online:2019-04-20 Published:2019-03-25
Contact: Zhang Xianwei E-mail:zxianw@163.com
Supported by:
the National Natural Science Foundation of China(31772555);the National Transgenic Major Projects(2016ZX08006002)

摘要/Abstract

摘要：

基因组DNA发生双链断裂(double strand break, DSB)后主要通过同源定向修复(homologous-directed repair, HDR)和非同源末端连接(nonhomologous end joining, NHEJ)两种途径进行修复,其中单链寡聚核苷酸(single-stranded oligodeoxyribonucleotide, ssODN)介导的同源定向修复是动物基因组常用的基因组定点修饰技术,具有较大的科研和应用价值。为提高猪基因组ssODN介导HDR效率,本研究以猪胎儿成纤维细胞(porcine fetal fibroblasts, PFFs)为研究对象,利用丝裂原活化的细胞外信号调节激酶(mitogen-activated extracellular signal-regulated kinase, MEK)抑制剂PD0325901培养细胞,研究其对HDR效率的影响及作用分子机理。结果显示,PD0325901能显著提高PFFs的G₂期和S期细胞群百分比,减少G₁期细胞群比率,促进HDR修复因子的表达。在最适浓度250 nmol/L时,PD0325901使ssODN介导的GFP报告载体的修复效率提高了58.8%;同时使PFFs基因组位点DMD和ROSA26定点修饰效率分别提高了48.16%和17.64%。本研究表明,MEK抑制剂PD0325901能显著提高猪基因组ssODN介导的同源定向修复效率,为高效制备定点基因修饰动物模型提供了新思路。

关键词: MEK抑制剂, 同源定向修复(HDR), PD0325901, 基因编辑

Abstract:

There are two major pathways, homology-directed repair (HDR) and nonhomologous end joining (NHEJ), involved in double-strand break (DSB) repair. Single-stranded oligodeoxyribonucleotide (ssODN)-mediated homologous recombination repair is commonly used for animal site-directed genome editing, with great scientific and practical value. To improve ssODN-mediated HDR efficiency in the pig genome, we investigated the effect and molecular mechanism of mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor PD0325901 on the HDR efficiency in porcine fetal fibroblasts (PFFs). The results showed that PD0325901 obviously increased the percentage of G₂ and S phase cell populations and reduced the cell population ratio in the G₁ phase of PFFs, and promoted the expression of HDR repair factor. At the optimal concentration of 250 nmol/L, PD0325901 increased the repair efficiency of ssODN-mediated GFP reporter vector by 58.8% and the directed editing efficiency of PFF DMD and ROSA26 locus by 48.16% and 17.64%, respectively. The results show that MEK inhibitor PD0325901 significantly promotes the efficiency of ssODN-mediated homologous-directed repair in the porcine genome, thus offering a new idea to generate genetically modified pigs more effectively.

Key words: MEK inhibitor, homologous-directed repair (HDR), PD0325901, gene editing

欧浩,李国玲,王豪强,黄广燕,蔡更元,李紫聪,吴珍芳,张献伟. MEK抑制剂PD0325901显著提高猪胎儿成纤维细胞ssODN介导的HDR效率[J]. 遗传, 2019, 41(4): 327-336.

Ou Hao,Li Guoling,Wang Haoqiang,Huang Guangyan,Cai Gengyuan,Li Zicong,Wu Zhenfang,Zhang Xianwei. MEK inhibitor PD0325901 significantly boosts ssODN-mediated HDR efficiency in porcine fetal fibroblasts[J]. Hereditas(Beijing), 2019, 41(4): 327-336.

参考文献

[1]	Kim YG, Cha J, Chandrasegaran S . Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA, 1996,93(3):1156-1160.
[2]	Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U . Breaking the code of DNA binding specificity of TAL-typeⅢeffectors. Science, 2009,326(5959):1509-1512.
[3]	Hsu PD, Lander ES, Zhang F . Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014,157(6):1262-1278.
[4]	Xu S, Cao S, Zou B, Yue Y, Gu C, Chen X, Wang P, Dong X, Xiang Z, Li K, Zhu M, Zhao Q, Zhou G . An alternative novel tool for DNA editing without target sequence limitation: the structure-guided nuclease. Genome Biol, 2016,17(1):186.
[5]	Huang YQ, Li GL, Yang HQ, Wu ZF . Progress and application of genome-edited pigs in biomedical research. Hereditas(Beijing), 2018,40(8):632-646.
[5]	黄耀强, 李国玲, 杨化强, 吴珍芳 . 基因编辑猪在生物医学研究中的应用. 遗传, 2018,40(8):632-646.
[6]	Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Ried T, Nussenzweig A . DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature, 2000,404(6777):510-514.
[7]	Capecchi MR . Altering the genome by homologous recombination. Science, 1989,244(4910):1288-1292.
[8]	Chen F, Pruett-Miller SM, Huang Y, Gjoka M, Duda K, Taunton J, Collingwood TN, Frodin M, Davis G . High- frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods, 2011,8(9):753-755.
[9]	Shen B, Zhang X, Du Y, Wang J, Gong J, Zhang X, Tate PH, Li H, Huang X, Zhang W . Efficient knockin mouse generation by ssDNA oligonucleotides and zinc-finger nuclease assisted homologous recombination in zygotes. PLoS One, 2013,8(10):e77696.
[10]	Hu Z, Shi Z, Guo X, Jiang B, Wang G, Luo D, Chen Y, Zhu YS . Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells. Cell Biosci, 2018,8(1):12.
[11]	Richardson CD, Kazane KR, Feng SJ, Zelin E, Bray NL, Schäfer AJ, Floor SN, Corn JE . CRISPR-Cas9 genome editing in human cells occurs via the Fanconi anemia pathway. Nat Genet, 2018,50(8):1132-1139.
[12]	Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL . Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol, 2015,33(5):538-542.
[13]	Ma X, Chen X, Jin Y, Ge W, Wang W, Kong L, Ji J, Guo X, Huang J, Feng XH, Fu J, Zhu S . Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells. Nat Commun, 2018,9(1):1303.
[14]	Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kühn R . Increasing the efficiency of homology- directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol, 2015,33(5):543-548.
[15]	Li G, Zhang X, Zhong C, Mo J, Quan R, Yang J, Liu D, Li Z, Yang H, Wu Z . Small molecules enhance CRISPR/ Cas9-mediated homology-directed genome editing in primary cells. Sci Rep, 2017,7(1):8943.
[16]	Gerlach M, Kraft T, Brenner B, Petersen B, Niemann H, Montag J . Efficient Knock-in of a point mutation in porcine fibroblasts using the CRISPR/Cas9-GMNN fusion gene. Genes, 2018,9(6):296.
[17]	Li GL, Zhong CL, Mo JX, Quan R, Wu ZF, Li ZC, Yang HQ, Zhang XW . Advances in site-specific integration of transgene in animal genome. Hereditas(Beijing), 2017,39(2):98-109.
[17]	李国玲, 钟翠丽, 莫健新, 全绒, 吴珍芳, 李紫聪, 杨化强, 张献伟 . 动物基因组定点整合转基因技术研究进展. 遗传, 2017,39(2):98-109.
[18]	Hao P Q, An S, Yang Y, Liu Y, Guo XX, Xu TR . The progress on MEK kinases and their inhibitors. Chin J Cell Biol, 2015,37(10):1425-1431.
[18]	郝佩琪, 安输, 杨洋, 刘莹, 郭晓汐, 徐天瑞 . MEK激酶及其抑制剂的研究进展. 中国细胞生物学学报, 2015,37(10):1425-1431.
[19]	Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E . MEK in cancer and cancer therapy. Pharmacol Therapeut, 2014,141(2):160-171.
[20]	Zhao Y, Adjei AA . The clinical development of MEK inhibitors. Nat Rev Clin Oncol, 2014,11(7):385-400.
[21]	Lin Z, Zhang Y, Gao T, Wang L, Zhang Q, Zhou J, Zhao J . Homologous recombination efficiency enhanced by inhibition of MEK and GSK3β. Genesis, 2014,52(11):889-896.
[22]	Roberts RG . Dystrophin, its gene, and the dystrophinopathies. Adv Genet, 1995,33:177-231.
[23]	Li X, Yang Y, Bu L, Guo X, Tang C, Song J, Fan N, Zhao B, Ouyang Z, Liu Z, Zhao Y, Yi X, Quan L, Liu S, Yang Z, Ouyang H, Chen YE, Wang Z, Lai L . Rosa26-targeted swine models for stable gene over-expression and Cre-mediated lineage tracing. Cell Res, 2014,24(4):501-504.
[24]	Li G, Liu D, Zhang X, Quan R, Zhong C, Mo J, Huang Y, Wang H, Ruan X, Xu Z, Zheng E, Gu T, Hong L, Li Z, Wu Z, Yang H . Suppressing Ku70/Ku80 expression elevates homology-directed repair efficiency in primary fibroblasts. Int J Biochem Cell Bi, 2018,99:154-160.
[25]	Stemmer M, Thumberger T, Del Sol Keyer M, Wittbrodt J, Mateo JL . CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLoS One, 2015,10(4):e0124633.
[26]	Labuhn M, Adams FF, Ng M, Knoess S, Schambach A, Charpentier EM, Schwarzer A, Mateo JL, Klusmann JH, Heckl D . Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications. Nucleic Acids Rese, 2018,46(3):1375-1385.
[27]	Yang D, Scavuzzo MA, Chmielowiec J, Sharp R, Bajic A, Borowiak M . Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases. Sci Rep, 2016,6:21264.
[28]	Lin S, Staahl BT, Alla RK, Doudna JA . Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife, 2014,3:e04766.
[29]	Weber JD, Raben DM, Phillips PJ, Baldassare JJ . Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J, 1997,326(Pt 1):61-68.
[30]	Wang S, Wang S, Zhu XG, Zhang JQ, Qiao XM, Ye YJ, Liang B, Ma XT, Cui ZR . Significance of MEK-ERK cascade in the development of human breast carcinoma. Chin J Surg, 2002,40(3):171-174.
[30]	王殊, 王杉, 祝学光, 张嘉庆, 乔新民, 叶颖江, 梁斌, 马向涛, 崔志荣 . 细胞外信号调节激酶及其上游激酶在人乳腺癌发生发展中的意义. 中华外科杂志, 2002,40(3):171-174.
[31]	Ayub A, Yip WK, Seow HF . Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell line. Biomed Pharmacother, 2015,75:40-50.
[32]	Chiruvella KK, Liang Z, Wilson TE . Repair of double- strand breaks by end joining. CSH Perspect Biol, 2013,5(5):a012757.
[33]	Karanam K, Kafri R, Loewer A, Lahav G . Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase. Mol Cell, 2012,47(2):320-329.
[34]	Branzei D, Foiani M . Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Bio, 2008,9(4):297-308.
[35]	Ceccaldi R, Rondinelli B, D'Andrea AD . Repair pathway choices and consequences at the Double-Strand break. Trends Cell Biol, 2015,26(1):52-64.
[36]	Li X, Heyer WD . Homologous recombination in DNA repair and DNA damage tolerance. Cell Res, 2008,18(1):99-113.
[37]	Kachhap SK, Rosmus N, Collis SJ, Kortenhorst MS, Wissing MD, Hedayati M, Shabbeer S, Mendonca J, Deangelis J, Marchionni L, Lin J, Höti N, Nortier JW, DeWeese TL, Hammers H, Carducci MA . Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor. PLoS One, 2010,5(6):e11208.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

MEK抑制剂PD0325901显著提高猪胎儿成纤维细胞ssODN介导的HDR效率

MEK inhibitor PD0325901 significantly boosts ssODN-mediated HDR efficiency in porcine fetal fibroblasts

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

编辑推荐

Metrics

[1]	杨新萍,于媛,许操. 重新设计与快速驯化创造新型作物[J]. 遗传, 2019, 41(9): 827-835.
[2]	张倩倩,商璇,林宛颖,徐湘民. 影响β-地中海贫血表型的遗传修饰作用[J]. 遗传, 2019, 41(8): 669-676.
[3]	牛煦然,尹树明,陈曦,邵婷婷,李大力. 基因编辑技术及其在疾病治疗中的研究进展[J]. 遗传, 2019, 41(7): 582-598.
[4]	任云晓, 肖茹丹, 娄晓敏, 方向东. 基因编辑技术及其在基因治疗中的应用[J]. 遗传, 2019, 41(1): 18-27.
[5]	黄耀强,李国玲,杨化强,吴珍芳. 基因编辑猪在生物医学研究中的应用[J]. 遗传, 2018, 40(8): 632-646.
[6]	辛高伟, 胡熙璕, 王克剑, 王兴春. Cas9蛋白变体VQR高效识别水稻NGAC前间区序列邻近基序[J]. 遗传, 2018, 40(12): 1112-1119.
[7]	陈一欧, 宝颖, 马华峥, 伊宗裔, 周卓, 魏文胜. 基因编辑技术及其在中国的研究发展[J]. 遗传, 2018, 40(10): 900-915.
[8]	马丽, 陈红岩, 朱化星, 李威, 卢大儒. 利用锁核酸化学偶联FokⅠ核酸酶靶向切割HBV基因的体外实验[J]. 遗传, 2016, 38(4): 350-359.
[9]	王大勇, 马宁, 惠洋, 高旭. CRISPR/Cas9基因组编辑技术在癌症研究中的应用[J]. 遗传, 2016, 38(1): 1-8.
[10]	殷利眷,胡斯奇,郭斐. CRISPR-Cas9基因编辑技术在病毒感染疾病治疗中的应用[J]. 遗传, 2015, 37(5): 412-418.
[11]	刘改改,李爽,韦余达,张永贤,丁秋蓉. 利用CRISPR/Cas9技术对人多能干细胞进行高效基因组编辑[J]. 遗传, 2015, 37(11): 1167-1173.
[12]	李晨, 楼慧强. 酵母基因编辑技术：从单基因操作到基因组重建[J]. 遗传, 2015, 37(10): 1021-1028.